GGrantIndex
← Search

CLINICAL ASSESSMENT OF CX-011 FOR PAIN RELIEF, INCREASED FUNCTION, AND POTENTIAL DISEASE-MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS

$488,483FY2025Defense Health AgencyDOD

Carthronix, Inc., Tarzana CA

Investigators

View source on USAspending →